Atorvastatin in moderat active Crohns disease.

Trial Profile

Atorvastatin in moderat active Crohns disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jul 2011 New trial record
    • 19 Oct 2007 New source identified and integrated (NCT00454545, 010-02) (ClinicalTrials.gov: US National Institutes of Health).
    • 19 Oct 2007 Actual end date (October 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top